About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Sirpatm1Umri
targeted mutation 1, Hisashi Umemori
MGI:5558020
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Sirpatm1Umri/Sirpatm1Umri
Tg(CAG-cre/Esr1*)1Lbe/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:5558023


Genotype
MGI:5558023
cn1
Allelic
Composition
Sirpatm1Umri/Sirpatm1Umri
Tg(CAG-cre/Esr1*)1Lbe/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sirpatm1Umri mutation (0 available); any Sirpa mutation (50 available)
Tg(CAG-cre/Esr1*)1Lbe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• as determined by VGLUT1 (Slc17a7) staining, mice treated with tamoxifen at P15 exhibit impaired maturation of presynaptic terminals compared with control mice
• however, mice treated tamoxifen at P0 exhibit normal initial synapse development and mice treated at P30 exhibit normal synapse maintenance
• irregular shape in tamoxifen-treated mice
• tamoxifen treated mice exhibit fewer synaptic vesicles and fewer docked synaptic vesicles in asymmetric synapses compared with control mice
• strongly diminished Input-output curves of field excitatory postsynaptic potential slope in tamoxifen-treated mice
• however, fiber volley amplitude is normal
• in tamoxifen-treated mice
• in tamoxifen-treated mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory